Clinical Trials Directory

Trials / Unknown

UnknownNCT05495113

The Efficacy and Safety of tDCS in Patients With Mild Dementia

In a Patient With Mild Dementia, Improvement of Cognitive Function Using YMS-201B, To Evaluate the Effectiveness and Safety, Randomized, Double-blinded, Sham Control Comparison, Confirmatory

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
118 (estimated)
Sponsor
Ybrain Inc. · Industry
Sex
All
Age
55 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study evaluated the effectiveness and safety of improving Mild Dementia by applying tDCS for 26 weeks to patients with Mild Dementia.

Detailed description

Patients received tDCS for 30 minutes with an intensity of 1.5 to 2 mA. tDCS was applied over the left (anode) and right (cathode) dorsolateral prefrontal cortex (DLPFC) 5\~7 times a week and they were evaluated every 26weeks through questionnaires.

Conditions

Interventions

TypeNameDescription
DEVICEYMS-201B (Device: Mind STIM)transcranial Direct Current Stimulation (tDCS) 2mA for 30 min; 30 sec of ramp-up and -down; left (anode) and right (cathode) Dorsolateral prefrontal cortex (DLPFC)
DEVICESham stimulation using YMS-201BSham stimulation; only 30 sec of ramp-up and -down; left (anode) and right (cathode) Dorsolateral prefrontal cortex (DLPFC)

Timeline

Start date
2019-12-01
Primary completion
2022-09-30
Completion
2022-12-30
First posted
2022-08-10
Last updated
2022-09-28

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05495113. Inclusion in this directory is not an endorsement.